UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C.  20549
                        Form 10-Q


X  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 
   SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 1995

    OR                                                    

   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 
   SECURITIES EXCHANGE  ACT OF 1934
                                                       
For the transition period from                to          
                                                       
Commission file number   1-07151
                         -------

                       THE CLOROX COMPANY
---------------------------------------------------------------
     (Exact name of registrant as specified in its charter)
                                                       

     DELAWARE                                    31-0595760
---------------------------------------------------------------
(State or other jurisdiction                  (I.R.S. Employer
 of incorporation or organization           Identification number)
                              
1221 Broadway - Oakland, California 94612 - 1888
---------------------------------------------------------------
(Address of principal executive offices)
                                        
Registrant's telephone number,                   (510)-271-7000
 (including area code)                           --------------

---------------------------------------------------------------
(Former name, former address and former fiscal year,
 if changed since last report)  

Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.
                                                         
          Yes         X           No                 
                     ---

As of September 30, 1995 there were 52,275,671 shares outstanding
of the registrant's common stock (par-value - $1.00), the 
registrant's only outstanding class of stock.
                                             
Total pages 9

<PAGE>

                            THE CLOROX COMPANY
                         
PART 1.  Financial Information                        Page No. 
                                                      ---------
  Item 1.  Financial Statements           

             Condensed Statements of                      3
             Consolidated Earnings
             Three Ended September 30, 1995 and 1994       


             Condensed Consolidated Balance Sheets        4   
             March 31, 1995 and June 30, 1994
             September 30, 1995 and June 30, 1995          
                          
                   
             Condensed Statements of Consolidated         5
             Cash Flows            
             Nine Months Ended March 31, 1995 and 1994
             Three Months Ended September 30, 1995 
             and 1994                                     
                          
                         
             Notes to Condensed Consolidated              6
             Financial Statements          
                         
                         
  Item 2.  Management's Discussion and Analysis           7-8
           of Results of Operations and 
           Financial Condition

2
<PAGE>
<TABLE>
<CAPTION>

                                     PART I - FINANCIAL INFORMATION
                                      Item 1. Financial Statements
                                   The Clorox Company and Subsidiaries
                              Condensed Statements of Consolidated Earnings
                                (In thousands, except per-share amounts)
                         
                                                             Three Months Ended
                                                       ------------------------------
                                                       9/30/95                9/30/94
                                                    ----------             ----------
<S>                                                 <C>                    <C>

Net Sales                                           $  518,486             $  476,367      
                                                     
Costs and Expenses                                                      
     Cost of products sold                             231,333                210,134      
                                                     
     Selling, delivery and administration               98,656                 89,471      
                                                     
     Advertising                                        72,482                 70,967      
                                                     
     Research and development                           10,202                 10,100      
                                                     
     Interest expense                                    7,772                  4,926      
                                                     
     Other (income) expense, net                          (567)                   362      
                                                     ----------             ---------
          Total costs and expenses                     419,878                385,960      
                                                     ----------             ---------
                                                     
Earnings before income taxes                            98,608                 90,407      
                                                     
Income Taxes                                            39,829                 37,226      
                                                     ----------             ---------
                                                     
Net Earnings                                         $  58,779              $  53,181      
                                                     ==========             =========

Earnings per Common Share                            $    1.12              $    1.00      
                                                     
Dividends per Share                                  $    0.53              $    0.48      
                                                     
Weighted Average Shares Outstanding                     52,354                 53,408      
                                                       
See Notes to Condensed Consolidated Financial Statements.
3
</TABLE>
<PAGE>

<TABLE>
<CAPTION>

                               PART I - FINANCIAL INFORMATION (Continued)
                                    Item 1. Financial Statements
                                The Clorox Company and Subsidiaries
                               Condensed Consolidated Balance Sheets
                                         (In thousands)
                                  
                                                             9/30/95                6/30/95      
                                                        ------------           ------------

<S>                                                     <C>                    <C>
ASSETS                                              
     Current Assets         
          Cash and short-term investments               $    127,846           $    137,330 
          Accounts receivable, less allowance                218,338                311,868 
          Inventories                                        128,450                121,095 
          Deferred income taxes                               11,575                 11,495 
          Prepaid expenses                                    17,091                 18,543 
                                                        ------------           ------------
               Total current assets                          503,300                600,331 
                                                  
     Property, Plant and Equipment - Net                     533,187                524,972 
                                                  
     Brands, Trademarks, Patents and Other Intangibles       604,575                592,792 
                                                  
     Investments in Affiliates                                97,228                 96,385 
                                                  
     Other Assets                                            119,053                 92,192 
                                                        ------------           ------------
     Total                                              $  1,857,343           $  1,906,672 


LIABILITIES AND STOCKHOLDERS' EQUITY                                                   
     Current Liabilities                                              
          Accounts payable                              $     99,187           $    122,763 
          Accrued liabilities                                212,451                234,595 
          Income taxes payable                                37,964                  6,283 
          Commercial paper and short-term borrowings          76,422                115,303 
          Current maturities of long-term debt                   305                    379 
                                                        ------------           ------------
               Total current liabilities                     426,329                479,323 
                                                  
     Long-term Debt                                          253,418                253,079 
                                              
     Other Obligations                                        79,611                 85,129 
                                                  
     Deferred Income Taxes                                   141,058                145,228 
                                              
     Stockholders' Equity                                              
          Common Stock                                        55,422                 55,422 
          Additional paid-in capital                         108,812                108,347 
          Retained earnings                                1,001,044                971,380 
          Treasury shares, at cost                          (179,201)              (168,217) 
          Cumulative translation adjustments and other       (29,150)               (23,019) 
               Stockholders' Equity                          956,927                943,913 
                                                        ------------           ------------
     Total                                              $  1,857,343            $ 1,906,672 
                                             
See Notes to Condensed Consolidated Financial Statements.                                              
4 
</TABLE>
<PAGE>

<TABLE>
<CAPTION>


                                 PART I - FINANCIAL INFORMATION (Continued)
                                      Item 1.  Financial Statements
                                    The Clorox Company and Subsidiaries
                               Condensed Statements of Consolidated Cash Flows
                                               (In thousands)

                                                               Three Months Ended                     
                                                         ------------------------------
                                                         9/30/95                9/30/94
                                                         ----------             ----------

<S>                                                      <C>                    <C>
Operations:                                              
     Net earnings                                        $   58,779             $   53,181 
     Adjustments to reconcile to net cash
      provided by operating activities:                                            
          Depreciation and amortization                      26,478                 25,305 
          Deferred income taxes                               3,300                  3,900 
          Other                                               4,628                  1,060 
          Effects of changes in:                                       
               Accounts  receivable                          93,933                 59,187 
               Inventories                                   (3,884)                (7,163) 
               Prepaid expenses                               1,372                  3,235 
               Accounts payable                             (22,603)                (9,904) 
               Accrued liabilities                          (18,065)               (34,015) 
               Income taxes payable                          24,211                 26,599 
                                                          ---------              ---------
               Net cash provided by operations              168,149                121,385 

Investing Activities:                                                 
     Property, plant and equipment                          (12,162)               (11,217) 
     Disposal of property, plant and equipment                2,369                    124 
     Businesses purchased                                   (60,427)               (18,095) 
     Other                                                  (15,736)                (9,081) 
                                                          ---------              ---------
               Net cash used for investment                 (85,956)               (38,269) 
                                                
Financing Activities:                                              
     Short-term borrowings                                     -                    (3,000) 
     Long-term borrowings                                      -                       154 
     Long-term debt and other obligations repayments         (8,789)                    - 
     Commercial paper, net                                  (38,881)               (21,934) 
     Cash dividends                                         (27,804)               (25,615) 
     Treasury stock purchased                               (18,819)                    - 
     Employee stock plan issuances                            2,616                  3,271 
                                                          ---------              ---------
               Net cash used for financing                  (91,677)               (47,124) 
                                                
Net (Decrease) Increase in Cash
 and Short-Term Investments                                  (9,484)                35,992 
Cash and Short-Term Investments:                                                 
     Beginning of period                                    137,330                115,922 
                                                          ---------              ---------
     End of period                                        $ 127,846              $ 151,914 


See Notes to Condensed Financial Statements                                              

5                                               
</TABLE>
<PAGE>


             PART I - FINANCIAL INFORMATION (Continued)
                 Item 1.  Financial Statements
               The Clorox Company and Subsidiaries
       Notes to Condensed Consolidated Financial Statements


(1)  The condensed consolidated financial statements for the 
     three months ended September 30, 1995 and 1994 has not 
     been audited, but in the opinion of management, all 
     adjustments (consisting only of normal recurring 
     accruals) necessary for a fair presentation of the results 
     of operations, financial position, and cash flows of The 
     Clorox Company and subsidiaries (the Company) have been 
     made.  The results of the three months ended September 30, 
     1995 should not be considered as necessarily indicative 
     of the results for the entire year.


(2)  Inventories at September 30, 1995 and at June 30, 1995 
     consisted of (in thousands):
                                              9/30/95     6/30/95
                                        
     Finished goods and work in process      $ 74,897    $ 71,102
     Raw materials and supplies                53,553      49,993
                                             --------    --------
          Total                              $128,450    $121,095


(3)  Stock Repurchases

     The Company's Board of Directors in July 1995, authorized a 
     $100,000,000 share repurchase program which is planned for 
     completion during fiscal year 1996.  The shares will be 
     purchased on the open market.  Shares reacquired will be 
     held as treasury shares and are available for reissuance 
     for corporate uses.  During the quarter, 278,600 shares 
     were repurchased at a cost of $18,819,000.


(4)  Acquisitions of $60,427,000 during the quarter were funded from
     cash and included the Black Flag line of insecticides acquired 
     in September 1995, the acquisition of the remaining minority 
     interest of the business in Argentina, and other business 
     interests in Mexico.  These acquisitions were accounted 
     for as purchases.

6
<PAGE>

                PART I - FINANCIAL INFORMATION (Continued)
            Item 2.  Management's Discussion and Analysis of
             Results of Operations and Financial Condition

Results of Operations

Comparison of the Three Months Ended September 30, 1995
with the Three Months Ended September  30, 1994

Earnings per share increased 12 percent to $1.12 from $1.00, and 
net earnings increased 11 percent to $58,779,000 from 
$53,181,000 a year ago principally due to a 9 percent increase 
in net sales driven by a 7 percent increase in volume.  Record 
shipments were recorded for our home cleaning business 
unit which includes Formula 409, Soft Scrub, Pine-Sol and 
Clorox toilet bowl cleaners.   This business unit achieved its 
eleventh consecutive quarterly increase in shipments.  Combat 
insecticides and Kingsford charcoal shipments were also first 
quarter records.  Brita water filtration systems shipped 
record quarterly volumes reflecting strong growth in all 
trade channels and the acquisition in January 1995 of the 
Brita business in Canada.  Our international business growth 
during the quarter was principally due to volume from businesses 
acquired in fiscal 1995.  Net sales for the quarter which 
benefited from price increases taken in fiscal 1995 for Clorox 
liquid bleach and Liquid-Plumr accounted for less than seven 
percent of the total increase.

Cost of products sold as a percentage of net sales was 44 
percent in both the current and year ago quarters.  Gross 
margins are anticipated to remain at approximately 56 percent 
for the remainder of the fiscal year.

Research and development expense was about even with the year 
ago period.  Selling, delivery, and administration expense 
increased 10 percent over the year ago period principally due 
to continued investment in international infrastructure, and 
costs implementing our customer interface project.

Advertising expenses increased 2 percent over the year ago 
period, and are anticipated to increase at the same rate as 
sales.

Interest expense increased $2,846,000 over the year ago period 
due to higher borrowing levels during the quarter and rates on 
commercial paper, and additional indebtedness related to the 
Brita Canada acquisition of January 1995.

7
<PAGE>

               PART I - FINANCIAL INFORMATION (Continued)
            Item 2.  Management's Discussion and Analysis of
              Results of Operations and Financial Condition

Liquidity and Capital Resources

The Company's financial position and liquidity remain strong due 
to cash provided by operations which increased $46,764,000 over 
the year ago period, principally due to the collection of June 30, 
1995 receivables including those with seasonal dating terms for 
payment  this period.  Cash provided by operations was used to fund
acquisitions of $60,427,000 during the quarter.  Decreases in 
accounts receivable and accounts payable balances from June 30, 
1995 reflect normal seasonal variation, due to the charcoal and 
insecticides businesses.  Inventories are higher than June 30, 1995 
principally due to international acquisitions.  We expect 
inventories to increase during the next two fiscal quarters to 
support the seasonal charcoal and insecticides businesses.

In July 1995, the Board of Directors approved a $100,000,000 
share repurchase program which is planned for completion 
during this fiscal year, subject to market conditions and 
business opportunities which may arise.  During the quarter 
278,600 shares at a cost of $18,819,000 were reacquired.

The Company has approved the use of interest rate derivative 
instruments such as interest rate swaps in order to manage 
the impact of interest rate movements on interest expense.  
These instruments have the effect of converting fixed rate 
interest to floating, or floating to fixed.  The conditions 
under which derivatives can be used are set forth in a Company 
Policy Statement and include a restriction on the amount of 
such activity to a designated portion of existing debt, a 
limit on the term of any derivative transaction, and a specific 
prohibition on the use of any leveraged derivatives.

Management believes the Company has access to additional capital 
through existing lines of credit and from public and private 
sources should the need arise.
8
<PAGE>


S I G N A T U R E


Pursuant to the requirements of the Securities Exchange Act of 
1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned thereunto duly authorized.


                                   THE CLOROX COMPANY
                                   (Registrant)




DATE November 14, 1994     BY /s/ HENRY J. SALVO, JR.
                              -----------------------
                              Henry J. Salvo, Jr.
                              Vice-President - Controller

9